Correspondingly, WNT2, WNT3A and β-catenin have previously demonstrated increased activity via IHC staining in both SSc and morphoea [71] and the role of Wnt-signalling in morphoea is established [20, 55, 71–75]. The gene discussed is WNT3A; the disease is systemic sclerosis.